DD215553A5 - Verfahren zur herstellung bizyklischer pyrimidin-5-on-abkoemmlinge - Google Patents

Verfahren zur herstellung bizyklischer pyrimidin-5-on-abkoemmlinge Download PDF

Info

Publication number
DD215553A5
DD215553A5 DD82241675A DD24167582A DD215553A5 DD 215553 A5 DD215553 A5 DD 215553A5 DD 82241675 A DD82241675 A DD 82241675A DD 24167582 A DD24167582 A DD 24167582A DD 215553 A5 DD215553 A5 DD 215553A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
parts
radical
acid
Prior art date
Application number
DD82241675A
Other languages
German (de)
English (en)
Inventor
Ludo E J Kennis
Josephus C Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DD215553A5 publication Critical patent/DD215553A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD82241675A 1981-07-15 1982-07-15 Verfahren zur herstellung bizyklischer pyrimidin-5-on-abkoemmlinge DD215553A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28359081A 1981-07-15 1981-07-15
US06/370,653 US4443451A (en) 1981-07-15 1982-04-21 Bicyclic pyrimidin-5-one derivatives

Publications (1)

Publication Number Publication Date
DD215553A5 true DD215553A5 (de) 1984-11-14

Family

ID=26962133

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82241675A DD215553A5 (de) 1981-07-15 1982-07-15 Verfahren zur herstellung bizyklischer pyrimidin-5-on-abkoemmlinge

Country Status (22)

Country Link
US (1) US4443451A (cs)
EP (1) EP0070053B1 (cs)
KR (1) KR870000868B1 (cs)
AU (1) AU547967B2 (cs)
CA (1) CA1207765A (cs)
CS (1) CS227690B2 (cs)
DD (1) DD215553A5 (cs)
DE (1) DE3270589D1 (cs)
DK (1) DK160314C (cs)
ES (1) ES513976A0 (cs)
FI (1) FI75828C (cs)
GR (1) GR76006B (cs)
HU (1) HU186952B (cs)
IE (1) IE53400B1 (cs)
MA (1) MA19536A1 (cs)
NO (1) NO166327C (cs)
NZ (1) NZ201266A (cs)
PH (1) PH18120A (cs)
PL (1) PL136680B1 (cs)
PT (1) PT75247B (cs)
SU (1) SU1138032A3 (cs)
YU (1) YU154682A (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535081A (en) * 1979-11-23 1985-08-13 Pfizer Inc. Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4533665A (en) * 1983-07-27 1985-08-06 Janssen Pharmaceutica [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
ATE146077T1 (de) * 1986-09-22 1996-12-15 Janssen Pharmaceutica Nv Serotonin-antagonisten zur behandlung von wunden
DE3634532A1 (de) * 1986-10-10 1988-04-14 Basf Ag Verfahren zur herstellung von thiazolo-(2,3-b)chinazolonen
US4921854A (en) * 1986-12-30 1990-05-01 Egis Gyogyszergyar Condensed thiazolopyrimidine, pyrimido-thiazine or thiazepine pyrimidine compounds
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
US5256659A (en) * 1989-01-09 1993-10-26 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
US5140029A (en) * 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
WO1992006086A1 (en) * 1990-10-01 1992-04-16 Janssen Pharmaceutica N.V. Novel 4-piperidinylcarbonyl derivatives
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
NZ254113A (en) * 1992-07-13 1995-08-28 Janssen Pharmaceutica Nv Fused piperidine derivatives and medicaments
DE4338396A1 (de) * 1993-11-10 1995-05-11 Basf Ag N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
JP3645906B2 (ja) * 1993-11-19 2005-05-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ マイクロカプセル封入された3−ピペリジニル−置換1,2−ベンズイソオキサゾール類及び1,2−ベンズイソチアゾール類
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
ES2097093B1 (es) * 1995-05-26 1998-01-16 Ferrer Int Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona.
US5962473A (en) * 1996-08-16 1999-10-05 Eli Lilly And Company Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
US6380201B1 (en) 1997-08-05 2002-04-30 Eli Lilly And Company Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists
EP1248770A1 (en) * 1999-12-16 2002-10-16 Biostream Therapeutics 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1615924A1 (en) * 2003-04-22 2006-01-18 Synthon B.V. Water soluble salts of risperidone
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
US7572249B2 (en) * 2006-12-01 2009-08-11 The Procter & Gamble Company Merchandise display systems for baby care articles
US7582075B2 (en) * 2006-08-24 2009-09-01 The Procter & Gamble Company Disposable absorbent article products with improved stages of development identification
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
KR101054189B1 (ko) * 2006-12-19 2011-08-03 에프. 호프만-라 로슈 아게 헤테로아릴 피롤리딘일 및 피페리딘일 케톤 유도체
BRPI0914160A2 (pt) * 2008-06-18 2019-09-24 Hoffmann La Roche aril cetona como mri
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1306558A (en) * 1970-08-14 1973-02-14 Seperic Derivatives of thiazolino-pyrimidin-5-ones their preparation and applications
GB1374281A (en) * 1971-08-24 1974-11-20 Seperic Thiazolino-pyrimidin-5-one derivatives process for their pre paration and applications thereof
JPS51146497A (en) * 1975-06-12 1976-12-16 Sankyo Co Ltd Process for preparing pyrido (1,2-a)pyrimidinone derivatives
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
US4471117A (en) * 1979-06-21 1984-09-11 Janssen Pharmaceutica N.V. 3,4-Dihydro-2H-pyrimido(2,1-b)benzothiazoles
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives

Also Published As

Publication number Publication date
EP0070053A2 (en) 1983-01-19
DE3270589D1 (de) 1986-05-22
CA1207765A (en) 1986-07-15
KR870000868B1 (ko) 1987-04-30
EP0070053B1 (en) 1986-04-16
HU186952B (en) 1985-10-28
DK160314C (da) 1991-07-29
NO822439L (no) 1983-01-17
ES8308327A1 (es) 1983-08-16
PL237492A1 (en) 1984-02-27
AU547967B2 (en) 1985-11-14
NZ201266A (en) 1985-01-31
GR76006B (cs) 1984-08-03
ES513976A0 (es) 1983-08-16
NO166327B (no) 1991-03-25
DK160314B (da) 1991-02-25
US4443451A (en) 1984-04-17
FI822511L (fi) 1983-01-16
CS227690B2 (en) 1984-05-14
FI822511A0 (fi) 1982-07-14
FI75828C (fi) 1988-08-08
PH18120A (en) 1985-03-22
PT75247A (en) 1982-08-01
PL136680B1 (en) 1986-03-31
SU1138032A3 (ru) 1985-01-30
YU154682A (en) 1985-03-20
DK316582A (da) 1983-01-16
NO166327C (no) 1991-07-10
IE821689L (en) 1983-01-15
KR840000568A (ko) 1984-02-25
PT75247B (en) 1985-01-07
IE53400B1 (en) 1988-11-09
EP0070053A3 (en) 1984-03-21
AU8575982A (en) 1983-01-20
MA19536A1 (fr) 1983-04-01
FI75828B (fi) 1988-04-29

Similar Documents

Publication Publication Date Title
DD215553A5 (de) Verfahren zur herstellung bizyklischer pyrimidin-5-on-abkoemmlinge
EP0037265B1 (en) 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-one derivatives
DE69420579T2 (de) 9-HYDROXY-PYRIDO [1,2-a] PYRIMIDIN-4-ON-ETHER-DERIVATE
DE69132119T2 (de) N-(4-Piperidinyl-)-dihydrobenzofuran- oder -dihydro-2H-benzopyran-carboxamidderivate
DE69008366T2 (de) 2-Aminopyrimidinon-Derivate.
DE3502508C2 (cs)
EP0110435B1 (en) Novel ((bis(aryl)methylene)-1-piperidinyl)alkyl-pyrimidinones
DE68910210T2 (de) (1-Hydroxy-2-piperidinylalkyl)-2-indolon, 2-quinolinon, 2-benzo[b]azepinon, 2-benzimidazolon und 2-quinazolinon-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
DE69131759T2 (de) An den Positionen 2 und 9 substituierte 4H-pyrido-(1,2-a)pyrimidin-4-one
DE3781173T2 (de) N-heterozyklische-4-piperidinamine enthaltende anti-histaminische zusammensetzungen.
DE69716062T2 (de) Benzofuran-derivate und deren verwendung
DE2300491A1 (de) Neue pyrrolo eckige klammer auf 3,4-b eckige klammer zu pyrazinderivate, ihre herstellung und die medizinischen zusammensetzungen, die sie enthalten
DE3689748T2 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und deren therapeutische Anwendung.
US4548938A (en) 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
DE69824872T2 (de) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridin derivate
DE69720715T2 (de) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
DE69629454T2 (de) Antipsychotische 4-(1h-indolyl-1-yl)-1-substituierte piperidine derivate
DE4116582A1 (de) Bicyclische 1-aza-cycloalkane
DE69330283T2 (de) Neue 4-(3-benzofuranyl) piperidinyl und 4-(3-benzothienyl) piperidinyl-derivate und diese enthaltende pharmazeutische zusammenstellungen
US4529727A (en) Pyrimido[2,1-b][1,3]-thiazines
DE3780015T2 (de) Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3785393T2 (de) 4-(aroylamino)piperidinbutanamide derivate.
DE69426528T2 (de) Antiallergische imidazoazepine
DE2423650A1 (de) Neue naphtyridinderivate, deren herstellung und diese enthaltende zusammensetzungen
DE1695228C2 (de) 5-Hydroxy-5-phenyl-2,3-dihydro-5H-imidazo-[2,1-a]isoindole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee